US regulators approve Wegovy pill, first oral medication to treat obesity
Food and Drug Administration’s approval hands drugmaker Novo Nordisk an edge in the race to market an obesity pillUS regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.The US Food and Drug Administration’s approval handed drugmaker Novo Nordisk an edge over rival Eli Lilly in the race to market an obesity pill. Lilly’s oral drug, orforglipron, is still under review. Continue reading...
Food and Drug Administration’s approval hands drugmaker Novo Nordisk an edge in the race to market an obesity pill
US regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
The US Food and Drug Administration’s approval handed drugmaker Novo Nordisk an edge over rival Eli Lilly in the race to market an obesity pill. Lilly’s oral drug, orforglipron, is still under review. Continue reading...
What's Your Reaction?
